Clinical Trial Update: Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating stem cell monitoring in chronic myeloid leukemia patients treated with nilotinib has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-03-25